Informing β-cell regeneration strategies using studies of
$ 19.50 · 4.9 (776) · In stock
Current therapeutic strategies for type 1 (T1DM) and type 2 diabetes mellitus (T2DM) rely on increasing or substituting endogenous insulin secretion i…
Identification of a LIF-Responsive, Replication-Competent
A: HbA 1c and 95% confidence limits over time by treatment group. B
Deficiency of transcription factor Nkx6.1 does not prevent insulin secretion in INS-1E cells
Katrina VILORIA, Post Doctoral Fellow, PhD Anatomy Pathology and Physiology, University of Birmingham, Birmingham, Institute of Metabolism and Systems Research
Frontiers Publishing Partnerships
The clinical implications of bacterial pathogenesis and mucosal
FDA's Framework for Regulating Regenerative Medicine Will Improve
Deficiency of transcription factor Nkx6.1 does not prevent insulin secretion in INS-1E cells
A: HbA 1c and 95% confidence limits over time by treatment group. B
Frontiers Mitogen Synergy: An Emerging Route to Boosting Human
Stem Cell Clinics in the United States: What You Need to Know
Gating strategy for T cell analysis. PBMC isolated from the
PDF) Laminin matrix regulates beta-cell FGFR5 expression to enhance glucose-stimulated metabolism